Communiqués DexCom, Inc. BOERSE MUENCHEN

Actions

DC4

US2521311074

Equipement, fournitures et distribution médicale

Temps réel BOERSE MUENCHEN Autres places de cotation 09:43:30 15/07/2026			Varia. 5j.	Varia. 1 janv.
64,91 ^EUR	0,00%		+0,79%	+13,52%

13/07	Le moniteur de glucose G7 de DexCom reçoit l'autorisation de Santé Canada pour les adultes diabétiques	MT
13/07	DexCom, Inc. annonce l'homologation par Santé Canada du système de surveillance continue du glucose Dexcom G7 15 jours	CI

Communiqués

13/07	Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes	PU
13/07	LE DEXCOM G7 15 JOURS A OBTENU L’AUTORISATION DE SANTÉ CANADA : UNE DURÉE DE PORT PROLONGÉE ET UNE CONTINUITÉ AMÉLIORÉE POUR LES ADULTES CANADIENS VIVANT AVEC LE DIABÈTE	BU
09/07	Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time	BU
03/07	Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?	PR
23/06	Dexcom Further Advances Vision of Glucose Biosensing for All	BU
06/06	Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin	BU
04/06	Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026	BU
02/06	Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience	BU
26/05	Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users	BU
19/05	DexCom : Operations and Innovation Committee	PU
18/05	Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany	BU
14/05	Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day	BU
06/05	DexCom : Trade Association Report 2025	PU
05/05	Dexcom to Host Investor Day on May 14, 2026	BU
30/04	DexCom: Q1 Earnings Snapshot	AQ
30/04	Dexcom Reports First Quarter 2026 Financial Results	BU
29/04	Why Medtech Giants Are Quietly Paying Up for AI Diagnostics	AQ
10/04	Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?	PR
02/04	Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time	BU
11/03	Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026	BU
26/02	Dexcom Appoints Rick Osterloh to Board of Directors	BU
26/02	HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS	PR
25/02	Dexcom Announces Upcoming Conference Presentation	BU
12/02	DexCom: Q4 Earnings Snapshot	AQ
12/02	Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results	BU